| For: | Guion-Dusserre JF, Bertaut A, Ghiringhelli F, Vincent J, Quipourt V, Marilier S, Tharin Z, Bengrine-Lefevre L. Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy. World J Gastroenterol 2016; 22(42): 9378-9386 [PMID: 27895425 DOI: 10.3748/wjg.v22.i42.9378] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i42/9378.htm |
| Number | Citing Articles |
| 1 |
Hui Tang, Zhengxia Li, Tingting You, Jinrong Ying, Yuejuan Cheng, Chunmei Bai, Yingyi Wang. Adjuvant FOLFIRINOX versus S-1 monotherapy for resected PDAC: retrospective real-world data. Therapeutic Advances in Medical Oncology 2026; 18 doi: 10.1177/17588359261470681
|
| 2 |
Gwenalyn Garcia, Marcel Odaimi. Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review. Journal of Gastrointestinal Cancer 2017; 48(2) doi: 10.1007/s12029-017-9930-0
|
| 3 |
T. Macarulla, A. Carrato, R. Díaz, A. García, B. Laquente, J. Sastre, R. Álvarez, A. Muñoz, M. Hidalgo. Management and supportive treatment of frail patients with metastatic pancreatic cancer. Journal of Geriatric Oncology 2019; 10(3) doi: 10.1016/j.jgo.2018.06.005
|
| 4 |
Maya N. White, Efrat Dotan, Paul J. Catalano, Dana B. Cardin, Jordan D. Berlin. Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients. Journal of Geriatric Oncology 2019; 10(4) doi: 10.1016/j.jgo.2018.11.001
|
| 5 |
Josenon Gomes Costa, Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Aldo Lourenço Abbade Dettino. Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experience. Therapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919874650
|
| 6 |
Heng‐Chung Kung, Jun Yu. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study. MedComm 2023; 4(2) doi: 10.1002/mco2.216
|
| 7 |
Grigorios Kotronoulas. Benefits, Challenges, and Opportunities of Integrating Patient-Reported Outcome Measures in Geriatric Oncology to Advance Patient Screening for Functional Fitness for Treatment. Seminars in Oncology Nursing 2021; 37(6) doi: 10.1016/j.soncn.2021.151230
|
| 8 |
M. Sh. Manukyan, I. S. Bazin, A. A. Tryakin. Chemotherapy for advanced pancreatic cancer in older patients (literature review). Surgery and Oncology 2022; 12(3) doi: 10.17650/2686-9594-2022-12-3-51-55
|
| 9 |
Stéphane Gerard, Zara Steinmeyer, Stéphanie Lozano, Marie Garric, Philippe Girard, Loic Mourey, Marion Deslandres, Gabor Abellan Van Kan, Laurent Balardy. Geriatric Oncology. 2020; doi: 10.1007/978-3-319-57415-8_61
|
| 10 |
Caterina Vivaldi, Francesca Salani, Giulia Rovesti, Irene Pecora, Silvia Catanese, Andrea Casadei-Gardini, Valentina Massa, Laura Bernardini, Laura Riggi, Kalliopi Andrikou, Giovanni I. Rapposelli, Vincenzo Formica, Monica Lencioni, Alfredo Falcone, Enrico Vasile, Lorenzo Fornaro. First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?. European Journal of Cancer 2020; 137 doi: 10.1016/j.ejca.2020.06.031
|
| 11 |
Louise André, Gabriel Antherieu, Amélie Boinet, Judith Bret, Thomas Gilbert, Rabia Boulahssass, Claire Falandry. Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review. Cancers 2022; 14(10) doi: 10.3390/cancers14102470
|
| 12 |
. 2020; doi: 10.70675/3fa3e18fz7fbcz4933z816az0d51aeb71255
|
| 13 |
Hao Xie, Junjia Liu, John R. Ogden, Jun Yin, Aminah Jatoi, Joleen M. Hubbard, Robert R. McWilliams, Amit Mahipal, Gloria M. Petersen, Tanios S. Bekaii-Saab, Wen Wee Ma. Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. American Journal of Clinical Oncology 2020; 43(8) doi: 10.1097/COC.0000000000000708
|
| 14 |
Erin N. McAndrew, Hanbo Zhang, Pascal Lambert, Rebekah Rittberg, David E. Dawe, Christina A. Kim. Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy. American Journal of Clinical Oncology 2022; 45(2) doi: 10.1097/COC.0000000000000882
|
| 15 |
Timothy N. O'Brien, Armin Shahrokni, Anne M. Horgan. Total Neoadjuvant Therapy for rectal cancer: Totally Not Translatable to the older patient?. Journal of Geriatric Oncology 2023; 14(1) doi: 10.1016/j.jgo.2022.07.008
|
| 16 |
May Tun Saung, Lei Zheng. Current Standards of Chemotherapy for Pancreatic Cancer. Clinical Therapeutics 2017; 39(11) doi: 10.1016/j.clinthera.2017.08.015
|
| 17 |
FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer. New England Journal of Medicine 2019; 380(12) doi: 10.1056/NEJMc1900712
|
| 18 |
Marloes Zoetemelk, George M. Ramzy, Magdalena Rausch, Patrycja Nowak-Sliwinska. Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment. Molecules 2020; 25(11) doi: 10.3390/molecules25112614
|
| 19 |
Marina Macchini, Marta Chiaravalli, Silvia Zanon, Umberto Peretti, Elena Mazza, Luca Gianni, Michele Reni. Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives. Cancer Treatment Reviews 2019; 72 doi: 10.1016/j.ctrv.2018.10.013
|
| 20 |
Kyle Sporn, Rahul Kumar, Ronald M. Caplan. Care of the Older Adult. 2026; doi: 10.1007/978-3-032-26761-0_40
|
| 21 |
T. Conroy, S. Gourgou, C. Borg. Authors’ reply to the Letters to the Editor discussing main outcomes of the PRODIGE 23 study. Annals of Oncology 2025; 36(2) doi: 10.1016/j.annonc.2024.10.007
|
| 22 |
Christian Schulz, Kerstin Schütte. Geriatrische gastrointestinale Onkologie: Leber, Galle, Pankreas. Der Gastroenterologe 2021; 16(5) doi: 10.1007/s11377-021-00549-9
|
| 23 |
Nicolás Tentoni, Ryan Combs, Miriam Hwang, Suzanne Ward, Andrea McCracken, Jennifer Lowe, Scott C. Howard. Long-Term Outcomes of 5-Fluorouracil-Related Early-Onset Toxicities: A Retrospective Cohort Study. Cancers 2024; 16(23) doi: 10.3390/cancers16234050
|
| 24 |
Laure Deyme, Dominique Barbolosi, Florence Gattacceca. Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters. Cancer Chemotherapy and Pharmacology 2019; 83(1) doi: 10.1007/s00280-018-3722-5
|
| 25 |
Lynda R. Corrigan, Dara M. Bracken-Clarke, Anne M. Horgan. The challenge of treating older patients with pancreaticobiliary malignancies. Current Problems in Cancer 2018; 42(1) doi: 10.1016/j.currproblcancer.2018.01.015
|
| 26 |
Alison Lewis, Adnan Nagrial. Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger Patients. Cancers 2023; 15(8) doi: 10.3390/cancers15082289
|
| 27 |
Giuseppe Colloca. Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysis. Asia-Pacific Journal of Clinical Oncology 2022; 18(3) doi: 10.1111/ajco.13598
|
| 28 |
L.J.H. Brada, M.S. Walma, R.M. van Dam, J. de Vos-Geelen, I.H. de Hingh, G.J. Creemers, M.S. Liem, L.J. Mekenkamp, V.E. de Meijer, D.J.A. de Groot, G.A. Patijn, J.W.B. de Groot, S. Festen, E.D. Kerver, M.W.J. Stommel, M.R. Meijerink, K. Bosscha, J.F. Pruijt, M.B. Polée, J.A. Ropela, G.A. Cirkel, M. Los, J.W. Wilmink, N. Haj Mohammad, H.C. van Santvoort, M.G. Besselink, I.Q. Molenaar. The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registry. Pancreatology 2021; 21(1) doi: 10.1016/j.pan.2020.11.012
|
| 29 |
Xiang Li, Da-bing Huang, Qi Zhang, Cheng-xiang Guo, Qi-han Fu, Xiao-chen Zhang, Tian-Yu Tang, Wei Su, Yi-Wen Chen, Wei Chen, Tao Ma, Shun-Liang Gao, Ri-Sheng Que, Xue-Li Bai, Ting-Bo Liang. The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer. Pancreatology 2020; 20(1) doi: 10.1016/j.pan.2019.11.012
|
| 30 |
Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido, Sabino De Placido, Luigi Formisano, Roberto Bianco. Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers 2021; 13(19) doi: 10.3390/cancers13194939
|
| 31 |
Satoshi Kobayashi, Makoto Ueno, Hiroshi Ishii, Junji Furuse. Management of elderly patients with unresectable pancreatic cancer. Japanese Journal of Clinical Oncology 2022; doi: 10.1093/jjco/hyac101
|
| 32 |
Anabela Barros, Catarina Pulido, Manuela Machado, Maria Brito, Nuno Couto, Olga Sousa, Sónia Melo, Hélder Mansinho. Treatment optimization of locally advanced and metastatic pancreatic cancer (Review). International Journal of Oncology 2021; 59(6) doi: 10.3892/ijo.2021.5290
|
| 33 |
Jennifer L. Olson, Richard J. Bold. Currently available first-line drug therapies for treating pancreatic cancer. Expert Opinion on Pharmacotherapy 2018; 19(17) doi: 10.1080/14656566.2018.1509954
|
| 34 |
Arthur Winer, Efrat Dotan. Treatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced Approach. Current Treatment Options in Oncology 2021; 22(11) doi: 10.1007/s11864-021-00892-7
|
| 35 |
Stéphane Gerard, Zara Steinmeyer, Stéphanie Lozano, Marie Garric, Philippe Girard, Loic Mourey, Marion Deslandres, Gabor Abellan Van Kan, Laurent Balardy. Geriatric Oncology. 2019; doi: 10.1007/978-3-319-44870-1_61-1
|
| 36 |
Kazuma Daiku, Kenji Ikezawa, Toshitaka Morishima, Yugo Kai, Ryoji Takada, Takuo Yamai, Isao Miyashiro, Kazuyoshi Ohkawa. Chemotherapy effectiveness and age-group analysis of older adult patients with metastatic pancreatic cancer: A Japanese cancer registry cohort study. Journal of Geriatric Oncology 2022; 13(8) doi: 10.1016/j.jgo.2022.07.010
|
| 37 |
Berenice Collineau, Cecile Bannier-Braticevic, Julia Gilhodes, Céline Delaunay, Elika Loir, Louis Tassy, Philippe Rochigneux, Damien Bruyat, Franck Espinosa, Christophe Manceau, Christelle de la Fouchardière, Emmanuel Mitry, Brice Chanez. Factors Associated With Toxicity of FOLFIRINOX in Elderly Patients With Pancreatic Ductal Adenocarcinoma. JCO Oncology Practice 2026; 22(4) doi: 10.1200/OP-25-00358
|
| 38 |
Marina Macchini, Marta Chiaravalli, Chiara Pircher, Silvia Zanon, Umberto Peretti, Elena Mazza, Maria Maddalena Valente, Clara Fugazza, Luca Gianni, Michele Reni. Multidrug regimens for treatment of older patients with metastatic pancreatic cancer. Digestive and Liver Disease 2021; 53(1) doi: 10.1016/j.dld.2020.06.006
|
| 39 |
Caspar Franck, Christian Müller, Rosa Rosania, Roland S. Croner, Maciej Pech, Marino Venerito. Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward. Cancers 2020; 12(7) doi: 10.3390/cancers12071955
|